Uniform-sized particles in biomedical field prepared by membrane emulsification technique

Chemical Engineering Science

Volumn 125, Issue , 2015, Pages 85-97

  Wu, Jie ^a   Fan, Qingze ^a,b   Xia, Yufei ^a,b   Ma, Guanghui ^a  

^a INSTITUTE OF PROCESS ENGINEERING   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Drug delivery system; Membrane emulsification; Uniform sized particles; Vaccine adjuvant

Indexed keywords

CONTROLLED DRUG DELIVERY; MEDICAL APPLICATIONS; SIZE DISTRIBUTION; TARGETED DRUG DELIVERY; VACCINES;

BIOMEDICAL APPLICATIONS; BROAD SIZE DISTRIBUTION; DRUG DELIVERY SYSTEM; MEMBRANE EMULSIFICATION; MEMBRANE EMULSIFICATION TECHNIQUE; NARROW SIZE DISTRIBUTIONS; UNIFORM-SIZED; VACCINE ADJUVANTS;

EMULSIFICATION;

EID: 84922335905     PISSN: 00092509     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ces.2014.08.016     Document Type: Article

References (94)

1. Ada G. Strategies for exploiting the immune system in the design of vaccines. Mol. Immunol. 1991, 28(3):225-230.
2. Anderson J.M., Shive M.S. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Deliv. Rev. 2012, 64(Suppl.):72-82.
3. Badiee A., Shargh V.H., Khamesipour A., Jaafari M.R. Micro/nanoparticle adjuvants for antileishmanial vaccines: present and future trends. Vaccine 2013, 31(5):735-749.
4. Bal S.M., Slütter B., Verheul R., Bouwstra J.A., Jiskoot W. Adjuvanted, antigen loaded N-trimethyl chitosan nanoparticles for nasal and intradermal vaccination: adjuvant- and site-dependent immunogenicity in mice. Eur. J. Pharm. Sci. 2012, 45(4):475-481.
5. Bysell H., Månsson R., Hansson P., Malmsten M. Microgels and microcapsules in peptide and protein drug delivery. Adv. Drug Deliv. Rev. 2011, 63(13):1172-1185.
6. Caldorera-Moore M., Kang M.K., Moore Z., Singh V., Sreenivasan S.V., Shi L., Huang R., Roy K. Swelling behavior of nanoscale, shape- and size-specific, hydrogel particles fabricated using imprint lithography. Soft Matter 2011, 7:2879-2887.
7. Chu L.Y., Utada A.S., Shah R.K., Kim J.-W., Weitz D.A. Controllable monodisperse multiple emulsions. Angew. Chem. Int. Ed. 2007, 119(47):9128-9132.
8. Desmarais S.M., Haagsman H.P., Barron A.E. Microfabricated devices for biomolecule encapsulation. Electrophoresis 2012, 33:2639-2649.
9. Diaz R.V., Llabrés M., Évora C. One-month sustained release microspheres of 125I-bovine calcitonin: In vitro-in vivo studies. J. Control Release 1999, 59(1):55-62.
10. Dohnal J., Štěpánek F. Inkjet fabrication and characterization of calcium alginate microcapsules. Powder Technol. 2010, 200(3):254-259.
11. Eldridge J.H., Hammond C.J., Meulbroek J.A. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches. J. Control Release 1990, 11(1-3):205-214.
12. ® technology. Nanomedicine 2013, 9(4):523-531.
13. Hao D.X., Gong F.L., Hu G.H., Zhao Y.J., Lian G.P., Ma G.H., Su Z.G. Controlling factors on droplets uniformity in membrane emulsification: experiment and modeling analysis. Ind. Eng. Chem. Res. 2008, 47(17):6418-6425.
14. Hao D.X., Gong F.L., Hu G.H., Lei J.D., Ma G.H., Su Z.G. The relationship between heterogeneous structures and phase separation in synthesis of uniform polyDVB microspheres. Polymer 2009, 50(14):3188-3195.
15. He C.B., Hu Y.P., Yin L.C., Tang C., Yin CH. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 2010, 31(13):3657-3666.
16. Heeger P.S., Kemper C. Novel roles of complement in T effector cell regulation. Immunobiology 2012, 217(2):216-224.
17. Ilyinskii P.O., Roy C.J., O'Neil C.P., Browning E.A., Pittet L.A., Altreuter D.H., Alexis F., Tonti E., Shi J.J., Basto P.A., Iannacone M., Radovic-Moreno A.F., Langer R.S., Farokhzad O.C., von Andrian U.H., Johnston L.P.M., Kishimoto T.K. Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release. Vaccine 2014, 32(24):2882-2895.
18. Iwanaga S., Saito N., Sanae H., Nakamura M. Facile fabrication of uniform size-controlled microparticles and potentiality for tandem drug delivery system of micro/nanoparticles. Colloid Surf. B 2013, 109:301-306.
19. Katare Y.K., Muthukumaran T., Panda A.K. Influence of particle size, antigen load, dose and additional adjuvant on the immune response from antigen loaded PLA microparticles. Int. J. Pharm. 2005, 301(1-2):149-160.
20. Klose D., Siepmann F., Elkharraz K., Krenzlin S., Siepmann J. How porosity and size affect the drug release mechanisms from PLGA-based microparticles. Int. J. Pharm. 2006, 314(2):198-206.
21. Kranz H., Bodmeier R. A novel in situ forming drug delivery system for controlled parenteral drug delivery. Int. J. Pharm. 2007, 332(1-2):107-114.
22. Kukizaki M. Preparation of solid lipid microcapsules via solid-in-oil-in-water dispersions by premix membrane emulsification. Chem. Eng. J. 2009, 151(1-3):387-396.
23. Kulkami S.A., Feng S.S. Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery. Pharm. Res. 2013, 30(10):2512-2522.
24. Lee H.K., Park J.H., Kwon K.C. Double-walled microparticles for single shot vaccine. J. Control Release 1997, 44(2-3):283-293.
25. Leleux J., Roy K. Micro and nanoparticle-based delivery systems for vaccine immunotherapy: an immunological and materials perspective. Adv. Healthc. Mater. 2013, 2(1):72-94.
26. Li K., Yu L., Liu X.J., Chen C., Chen Q.H., Ding J.D. A long-acting formulation of a polypeptide drug exenatide in treatment of diabetes using an injectable block copolymer hydrogel. Biomaterials 2013, 34(11):2834-2842.
27. Li X.H., Zhang Y.H., Yan R.H., Jia W.X., Yuan M.L., Deng X.M., Huang Z.T. Influence of process parameters on the protein stability encapsulated in poly-dl-lactide-poly(ethylene glycol) microspheres. J. Control Release 2000, 68(1):41-52.
28. Liu R., Ma G.H., Meng F.T., Su Z.G. Preparation of uniform-sized PLA microcapsules by combining Shirasu porous glass membrane emulsification technique and multiple emulsion-solvent evaporation method. J. Control Release 2005, 103(1):31-43.
29. Liu R., Ma G.H., Wan Y.H., Su Z.G. Influence of process parameters on the size distribution of PLA microcapsules prepared by combining membrane emulsification technique and double emulsion-solvent evaporation method. Colloid Surf. B 2005, 45(3-4):144-153.
30. Liu R., Huang S.S., Wan Y.H., Ma G.H., Su Z.G. Preparation of insulin-loaded PLA/PLGA microcapsules by a novel membrane emulsification method and its release in vitro. Colloid Surf. B. 2006, 51(1):30-38.
31. Liu Y., Yin Y., Wang L.Y., Zhang W.F., Chen X.M., Yang X.X., Xu J.J., Ma G.H. Surface hydrophobicity of microparticles modulates adjuvanticity. J. Mater. Chem. B 2013, 1(32):3888-3896.
32. Liu Y., Yin Y., Wang L.Y., Zhang W.F., Chen X.M., Yang X.X., Xu J.J., Ma G.H. Engineering biomaterial-associated complement activation to improve vaccine efficacy. Biomacromolecules 2013, 14(9):3321-3328.
33. Liu Z., Shum H.C. Fabrication of uniform multi-compartment particles using microfludic electrospray technology for cell co-culture studies. Biomicrofluidics 2013, 7(4):044117.
34. Liu Z.H., Jiao Y.P., Wang Y.F., Zhou C.R., Zhang Z.Y. Polysaccharides-based nanoparticles as drug delivery systems. Adv. Drug Deliv. Rev 2008, 60(15):1650-1662.
35. Lv P.P., Wei W., Gong F.L., Zhang Y.L., Zhao H.Y., Lei J.D., Wang L.Y., Ma G.H. Preparation of uniformly sized chitosan nanospheres by a premix membrane emulsification technique. Ind. Eng. Chem. Res. 2009, 48(19):8819-8828.
36. Lv P.P., Wei W., Yue H., Yang T.Y., Wang L.Y., Ma G.H. Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration. Biomacromolecules 2011, 12(12):4230-4239.
37. Ma G.H. Control of polymer particle size using porous glass membrane emulsification. China Part. 2003, 1(3):105-114.
38. Ma G.H., An C.J., Yuyama H., Su Z.G., Omi S. Synthesis and characterization of polyurethaneurea-vinyl polymer (PUU-VP) uniform hybrid microspheres by SPG emulsification technique and subsequent suspension polymerization. J. Appl. Polym. Sci. 2003, 89(1):163-178.
39. Ma G.H., Su Z.G., Omi S. Study of the effect of porogen amount on formation of uniform polystyrene hollow particles prepared by SPG membrane emulsification technique. Prog. Colloid Polym. Sci. 2004, 124:138-142.
40. Maderuelo C., Zarzuelo A., Lanao J.M. Critical factors in the release of drugs from sustained release hydrophilic matrices. J. Control Release 2011, 154(1):2-19.
41. Morçöl T., Nagappan P., Nerenbaum L., Mitchell A., Bell S.J.D. Calcium phosphate-PEG-insulin-casein (CAPIC) particles as oral delivery systems for insulin. Int. J. Pharm. 2004, 277(1-2):91-97.
42. Neimert-Andersson T., Hällgren A.C., Andersson M., Langebäck J., Zettergren L., Nilsen-Nygaard J., Draget K.I., van Hage M., Lindberg A., Gafvelin G., Grönlund H. Improved immune responses in mice using the novel chitosan adjuvant ViscoGel, with a Haemophilus influenzae type b glycoconjugate vaccine. Vaccine 2011, 29(48):8965-8973.
43. Okada H. One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate. Adv. Drug Deliv. Rev. 1997, 28(1):43-70.
44. Omi S. Preparation of monodisperse microspheres using the Shirasu porous glass emulsification technique. Colloid Surf. A 1996, 109:97-107.
45. Pan Y., Leifert A., Ruau D., Neuss S., Bornemann J., Schmid G., Brandau W., Simon U., Jahnen-Dechent W. Gold nanoparticles of diameter 1.4nm trigger necrosis by oxidative stress and mitochondrial damage. Small 2009, 5(18):2067-2076.
46. Pan Y., Neuss S., Leifert A., Fischler M., Wen F., Simon U., Schmid G., Brandau W., Jahnen-Dechent W. Size-dependent cytotoxicity of gold nanoparticles. Small 2007, 3(11):1941-1949.
47. Park M., Baek J.S., Lee C.A., Cho C.W. Effect of chitosan on physicochemical properties of exenatide-loaded PLGA nanoparticles. J. Pharm. Investig. 2013, 43(6):489-497.
48. Pawar D., Mangal S., Goswami R., Jaganathan K.S. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity. Eur. J. Pharm. Biopharm. 2013, 85(3):550-559.
49. Pillai P.P., Huda S., Kowalczyk B., Grzybowski B. Controlled pH stability and adjustable cellular uptake of mixed charge nanoparticles. J. Am. Chem. Soc. 2013, 135(17):6392-6395.
50. Prego C., Paolicelli P., Díaz B., Vicente S., Sánchez A., González-Fernández Á, Alonso M.J. Chitosan-based nanoparticles for improving immunization against hepatitis B infection. Vaccine 2010, 28(14):2607-2614.
51. Qi F., Wu J., Fan Q.Z., He F., Tian G.F., Yang T.Y., Ma G.H., Su Z.G. Preparation of uniform-sized exenatide-loaded PLGA microspheres as long-effective release system with high encapsulation efficiency and bio-stability. Colloid Surf. B 2013, 112:492-498.
52. Qi F., Wu J., Hao D.X., Yang T.Y., Ren Y., Ma G.H., Su Z.G. Comparative studies on the influences of primary emulsion preparation on properties of uniform-sized exenatide-loaded PLGA microspheres. Pharm. Res. 2014, 31(6):1566-1574.
53. Qi F., Wu J., Yang T.Y., Ma G.H. and Su Z.G., Mechanism studies for monodisperse exenatide-loaded PLGA microspheres prepared by different methods based on SPG membrane emulsification, Acta Biomater. , in press. http://dx.doi.org/10.1016/j.actbio.2014.06.018.
54. Reddy S.T., van der Vlies A.J., Simeoni E., Angeli V., Randolph G.J., O'Neill C.P., Lee L.K., Swartz M.A., Hubbell J.A. Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat. Biotechnol. 2007, 25(10):1159-1164.
55. Santos A.C., Cunha J., Veiga F., Cordeiro-da-Silva A., Ribeiro A.J. Ultrasonication of insulin-loaded microgel particles produced by internal gelation: Impact on particle's size and insulin bioactivity. Carbohydr. Polym. 2013, 98(2):1397-1408.
56. Scherlieβ R., Buske S., Young K., Weber B., Rades T., Hook S. In vivo evaluation of chitosan as an adjuvant in subcutaneous vaccine formulations. Vaccine 2013, 31(42):4812-4819.
57. Sivakumar S.M., Sukumarah N., Nirmala L., Swarnalakshmi R., Anilbabu B., Siva L., Anbu J., Shanmugarajan T.S., Ravichandran V. Immunopotentiation of Hepatitis B Vaccine biodegradable polymers as an adjuvant. J. Microbiol. Immunol. Infect. 2010, 43(4):265-270.
58. Smith, C., Christenson, T., Rickey, M.E., Wright, S.G., Lokensgard, D.M., Hotz, J.M., Kumar, R., Costantino, H.R., Yeoh, T.Y., (to Alkermes Controlled Therapeutics, Inc. and Amylin Pharmaceuticals, Inc.), 2005. Poly (lactide-co-glycolide)-based sustained release microcapsules comprising a polypeptide and a sugar. WO 2005102293.
59. Stewart P.M., Kane K.F., Stewart S.E., Lancranjan I., Sheppard M.C. Depot long-acting somatostatin analog (Sandostatin-LAR) is an effective treatment for acromegaly. J. Clin. Endocrinol. Metab. 1995, 80(11):3267-3272.
60. Suzuki K., Shuto I., Hagura Y. Characteristics of membrane emulsification method combined with preliminary emulsification for preparing corn oil-in-water emulsions. Food Sci. Technol. Int. 1996, 2(1):43-47.
61. Thomas C., Rawat A., Hope-Weeks L., Ahsan F. Aerosolized PLA and PLGA nanoparticles enhance humoral, mucosal and cytokine responses to Hepatitis B vaccine. Mol. Pharm. 2011, 8(2):405-415.
62. Thunberg S., Neimert-Andersson T., Cheng Q., Wermeling F., Bergström U., Swedin L., Dahlén S.E., Arnér E., Scheynius A., Karlsson M.C.I., Gafvelin G., van Hage M., Grönlund H. Prolonged antigen-exposure with carbohydrate particle based vaccination prevents allergic immune responses in sensitized mice. Allergy 2009, 64(6):919-926.
63. Velasquez L.S., Shira S., Berta A.N., Kilbourne J., Medi B.M., Tizard I., Ni Y.W., Arntzen C.J., Herbst-Kralovetz M.M. Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine. Vaccine 2011, 29(32):5221-5231.
64. Vladisavljević G.T., Williams R.A. Recent developments in manufacturing emulsions and particulate products using membranes. Adv. Colloid Interface 2005, 113(1):1-20.
65. Vladisavljević G.T., Kobayashi I., Nakajima M. Production of uniform droplets using membrane, microchannel and microfluidic emulsification devices. Microfluid. Nanofluid. 2012, 13(1):151-178.
66. Wang L.Y., Ma G.H., Su Z.G. Preparation of uniform sized chitosan microspheres by membrane emulsification technique and application as a carrier of protein drug. J. Control Release 2005, 106(1-2):62-75.
67. Wang L.Y., Gu Y.H., Zhou Q.Z., Ma G.H., Wan Y.H., Su Z.G. Preparation and characterization of uniform-sized chitosan microspheres containing insulin by membrane emulsification and a two-step solidification process. Colloid Surf. B 2006, 50(2):126-135.
68. Wang L.Y., Liu Y., Zhang W.F., Chen X.M., Yang T.Y., Ma G.H. Microspheres and microcapsules for protein delivery: strategies of drug activity retention. Curr. Pharm. Des. 2013, 19(35):6340-6352.
69. Wang T.Y., Jiang H.T., Zhao Q.F., Wang S.L., Zou M.J., Cheng G. Enhanced mucosal and systemic immune responses obtained by porous silica nanoparticles used as an oral vaccine adjuvant: effect of silica architecture on immunological properties. Int. J. Pharm. 2012, 436(1-2):351-358.
70. Wang W., Zhang M.J., Xie R., Ju X.J., Yang C., Mou C.L., Weitz D.A., Chu L.Y. Hole-shell microparticles from controllably evolved double emulsions. Angew. Chem. Int. Ed. 2013, 52(31):8084-8087.
71. Wang Y.Q., Wu J., Fan Q.Z., Zhou M., Yue Z.G., Ma G.H., Su Z.G. Novel vaccine delivery system induces robust humoral and cellular immune responses based on multiple mechanisms. Adv. Healthc. Mater. 2014, 3(5):670-681.
72. Wang Y.X., Qin J., Wei Y., Li C.P., Ma G.H. Preparation strategies of thermo-sensitive P(NIPAM-co-AA) microspheres with narrow size distribution. Powder Technol. 2013, 236:107-113.
73. Wei Q., Wei W., Lai B., Wang L.Y., Wang Y.X., Su Z.G., Ma G.H. Uniform-sized PLA nanoparticles: Preparation by premix membrane emulsification. Int. J. Pharm. 2008, 359(1-2):294-297.
74. Wei W., Wang L.Y., Yuan L., Yang X.D., Su Z.G., Ma G.H. Bioprocess of uniform-sized crosslinked chitosan microspheres in rats following oral administration. Eur. J. Pharm. Biopharm. 2008, 69(3):878-886.
75. Wei W., Yuan L., Hu G., Wang L.Y., Wu J., Hu X., Su Z.G., Ma G.H. Monodisperse chitosan microspheres with interesting structures for protein drug delivery. Adv. Mater. 2008, 20(12):2292-2296.
76. Wei W., Lv P.P., Chen X.M., Yue Z.G., Fu Q., Liu S.Y., Yue H., Ma G.H. Codelivery of mTERT siRNA and paclitaxel by chitosan-based nanoparticles promoted synergistic tumor suppression. Biomaterials 2013, 34(15):3912-3923.
77. Wei Y., Wang Y.X., Wang W., Ho S.V., Wei W., Ma G.H. mPEG-PLA microspheres with narrow size distribution increase the controlled release effect of recombinant human growth hormone. J. Mater. Chem. 2011, 21(34):12691-12699.
78. Wei Y., Wang Y.X., Wang W., Ho S.V., Qi F., Ma G.H., Su Z.G. Microcosmic mechanisms for protein incomplete release and stability of various amphiphilic mPEG-PLA microspheres. Langmuir 2012, 28(39):13984-13992.
79. Wei Y., Wang Y.X., Kang A.J., Wang W., Ho S.V., Gao J.F., Ma G.H., Su Z.G. A novel sustained-Release formulation of recombinant human growth hormone and its pharmacokinetic, pharmacodynamic and safety profiles. Mol. Pharm. 2012, 9(7):2039-2048.
80. Wu J., Wei W., Wang L.Y., Su Z.G., Ma G.H. Preparation of uniform-sized pH-sensitive quaternized chitosan microsphere by combining membrane emulsification technique and thermal-gelation method. Colloid Surf. B 2008, 63(2):164-175.
81. Yang J., Hao D.X., Bi C.X., Su Z.G., Wang L.Y., Ma G.H. Rapid synthesis of uniform magnetic microspheres by combing premix membrane emulsification and in situ formation techniques. Ind. Eng. Chem. Res. 2010, 49(13):6047-6053.
82. Yu S.H., Tang D.W., Hsieh H.Y., Wu W.S., Lin B.X., Chuang E.Y., Sung H.W., Mi F.L. Nanoparticle-induced tight-junction opening for the transport of an anti-angiogenic sulfated polysaccharide across Caco-2 cell monolayers. Acta Biomater. 2013, 9(7):7449-7459.
83. Yue H., Wei W., Yue Z.G., Lv P.P., Wang L.Y., Ma G.H., Su Z.G. Particle size affects the cellular response in macrophages. Eur. J. Pharm. Sci. 2010, 41(5):650-657.
84. Yue H., Wei W., Fan B., Yue Z.G., Wang L.Y., Ma G.H., Su Z.G. The orchestration of cellular and humoral responses is facilitated by divergent intracellular antigen trafficking in nanoparticle-based therapeutic vaccine. Pharmacol. Res. 2012, 65(2):189-197.
85. Yue Z.G., Wei W., Lv P.P., Yue H., Wang L.Y., Su Z.G., Ma Z.G. Surface charge affects cellular uptake and intracellular trafficking of chitosan-based nanoparticles. Biomacromolecules 2011, 12(7):2440-2446.
86. Yue Z.G., You Z.X., Yang Q.Z., Lv P.P., Yue H., Wang B., Ni D.Z., Su Z.G., Wei W., Ma G.H. Molecular structure matters: PEG-b-PLA nanoparticles with hydrophilicity and deformability demonstrate their advantages for high-performance delivery of anti-cancer drugs. J. Mater. Chem. B 2013, 1(26):3239-3247.
87. Zhang W.F., Wang L.Y., Liu Y., Chen X.M., Li J.H., Yang T.Y., An W.Q., Ma X.W., Pan R.W., Ma G.H. Comparison of PLA microparticles and alum as adjuvants for H5N1 influenza split vaccine: adjuvanticity evaluation and preliminary action mode analysis. Pharm. Res. 2014, 31(4):1015-1031.
88. Zhang W.F., Wang L.Y., Liu Y., Chen X.M., Liu Q., Jia J.L., Yang T.Y., Qiu S.H., Ma G.H. Immune responses to vaccines involving a combined antigen nanoparticle mixture and nanoparticle-encapsulated antigen formulation. Biomaterials 2014, 35(23):6086-6097.
89. Zhang Y.L., Wei W., Lv P.P., Wang L.Y., Ma G.H. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin. Eur. J. Pharm. Biopharm. 2011, 77(1):11-19.
90. Zhao X., Wu J., Gong F.L., Cui J.M., Janson J.C., Ma G.H., Su Z.G. Preparation of uniform and large sized agarose microspheres by an improved membrane emulsification technique. Powder Technol. 2014, 253:444-452.
91. Zhou Q.Z., Wang L.Y., Ma G.H., Su Z.G. Multi-stage premix membrane emulsification for preparation of agarose microbeads with uniform size. J. Membr. Sci. 2008, 322(1):98-104.
92. Zhou Q.Z., Ma G.H., Su Z.G. Effect of membrane parameters on the size and uniformity in preparing agarose beads by premix membrane emulsification. J. Membr. Sci. 2009, 326(2):694-700.
93. Zhou W.B., Bi J.X., Janson J.C., Li Y., Huang Y.D., Zhang Y., Su Z.G. Molecular characterization of recombinant Hepatitis B surface antigen from Chinese hamster ovary and Hansenula polymorpha cells by high-performance size exclusion chromatography and multi-angle laser light scattering. J. Chromatogr. B. 2006, 838(2):71-77.
94. Zhu L., Li Q., Gong F.L., Yan X.F., Li X.Q., Ma G.H., Su Z.G., Yuan Q.P. An insight into structure regulation of uniform polystyrene micro/nano-particles by porogen in premix membrane emulsification process. J. Membr. Sci. 2013, 448:248-255.